Vaccines

Barriers to recommended vaccine coverage for low-income American adults include disparity in Medicaid programs and low reimbursement amounts, a new study found.

What is the hopeful expectation of the new candidates, relative to previously developed vaccines?

Preventive medicine expert William Schaffner, MD, discusses what it will take for investigators to properly assess and manufacture a vaccine.

In a new phase 4 study, investigators found giving patients raxibacumab at the start of anthrax vaccine adsorbed administration does hurt the protective quality of the vaccine.

Moderna hopes to initiate phase 2 and late stage studies of its vaccine candidate, mRNA-1273, against COVID-19.

Flu burden for children can be reduced by improving adherence to a 2-dose series of flu vaccinations.

The attenuated virus in oral polio vaccines has developed the ability to evolve and spread to humans. Now, investigators have developed a new vaccine without the ability to make such changes.

Vaccination rates remain below recommended levels in many areas.

Disparate reimbursement policies disincentivize clinicians from vaccinating adults with lower incomes.

The authors of the review recommend the continued use of MMR vaccines on a mass scale.

Gain more insight on clinical trials evaluating investigational agents for COVID-19.

The differences do not mean that the measles vaccine is ineffective.

In mouse models, the vaccine produced antibodies for SARS-CoV-2 which may offer sufficient protection.

Ian Frank, MD, gives an overview of different HIV vaccine efforts in recent years and on the horizon.

A study has examined the availability of negative vaccine information online.

The 20vPnC pneumococcal conjugate vaccine candidate was found comparable to licensed products in safety and immunogenicity.

Colleen Kelley, MD, MPH, describes the current state of HIV vaccine efforts.

A new study demonstrates that the introduction of a universal immunization program had positive impact on the educational attainment of people in India’s school system.

A study has identified geographic and socioeconomic drivers of conscientious vaccine exemption choice in Texas.

The investigators of a new observational cohort study on incidence of tetanus and diphtheria in 31 countries have provided data that suggest no benefit associated with performing adult booster vaccinations.

Measles leave every organ system vulnerable and can lead to a wide range of serious complications, including hepatitis, appendicitis and viral meningitis, according to a new study.

A small but significant percentage of Americans believe common misconceptions about vaccines, and that misinformation was associated with social media use and lower trust of medical experts, a new study found.

Based on data from 4112 children and adults, vaccine effectiveness was estimated to be 37% against influenza A and 50% against influenza B viruses.

Pneumococcal conjugate vaccines have been effective at reducing pneumonia, sepsis, and bacteremia in immunized populations. Pneumococcal meningitis, however, remains a significant challenge.

A new study found that the Zoster Vaccine Live not only reduced the risk for shingles but also reduced stroke risk by 16% in older adults.

There could be viable options within a few months, but will it be in time to contain an outbreak?

The US Centers for Disease Control and Prevention Advisory Committee on Immunization Practices has released the 2020 Recommended Immunization Schedule for adults.

The CDC’s Advisory Committee on Immunization Practices have updated vaccine recommendations to allow interchangeable use of Tdap and Td in some cases.

A new study provides evidence that there was no change in herd immunity among more than 34,000 students in Australia with moderate to high vaccination rates.

A study comparing immunogenicity, safety, and interchangeability of JENVAC to an SA 14-14-2 strain derived vaccine has found JENVAC offers statistically higher immunological measures.